FDA clears Sectra's cardiovascular imaging technology

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
Sectra AB has received FDA approval for its analysis package for cardiovascular imaging.

The application provides physicians with analysis functions for quantifying arterial stenosis and overall heart function, including tools for quantitative coronary analysis (QCA) and left ventricle analysis (LVA).

Sectra's cardiology applications are designed to allow physicians access to specific clinical tools designed to support the diagnostic process, increase the reproducibility and improve workflow efficiency.